# INFINITY PHARMACEUTICALS INC (INFIQ)

> Institutional ownership reported to the SEC as of Q4 2023, from Form 13F filings. Source: https://holderbook.com/stocks/INFIQ/

- Reporting holders: 3
- Reported value: $15
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Highlander Capital Management, LLC](https://holderbook.com/funds/1519113-highlander-capital-management-llc/) | $9 | 3,500 | 0.0% | 1 |
| [Able Wealth Management LLC](https://holderbook.com/funds/2011908-able-wealth-management-llc/) | $5 | 2,000 | 0.0% | 1 |
| [Livelsberger Financial Advisory](https://holderbook.com/funds/2015721-livelsberger-financial-advisory/) | $1 | 200 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q4 2023 | 3 | $15 |
| Q3 2023 | 2 | $2.9K |
| Q2 2023 | 45 | $4.3M |
| Q1 2023 | 51 | $3.2M |
| Q4 2022 | 66 | $14.1M |
| Q3 2022 | 73 | $37.4M |
| Q2 2022 | 70 | $19.3M |
| Q1 2022 | 90 | $44.9M |
| Q4 2021 | 97 | $99.4M |
| Q3 2021 | 105 | $167.3M |
| Q2 2021 | 96 | $134.3M |
| Q1 2021 | 82 | $140.1M |